December 9 (SeeNews) - Bulgaria's Sopharma Trading [BUL:SO5] said on Monday that the chairman of its board of directors - Ognyan Donev, and its majority owner - drug maker Sopharma [BUL:3JR], have both increased their stakes in the company.
Sopharma acquired 500 Sopharma Trading shares, while Donev acquired 100 shares in the drug trader, Sopharma Trading said in two separate bourse filings.
Sopharma paid 5.68 levs ($3.21/2.90 euro) per share, while Donev paid 5.65 levs apiece.
At the end of September, Sopharma held a 72.97% stake in Sopharma Trading, while Donev owned directly a stake of under 5%.
Last week, Sopharma bought 1,000 Sopharma Trading shares, while Donev acquired 1,193 shares in the pharmaceuticals trader.
As at 11:00 CET on Monday Sopharma Trading's shares traded unchanged at 5.70 levs apiece. Sopharma's shares traded 0.29% lower at 3.43 levs.
(1 euro = 1.95583 levs)